SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q4 EPS of ($0.37), $0.15 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $17 million versus the consensus estimate of $17.33 million.

GUIDANCE:

SOPHiA GENETICS SA sees FY2024 revenue of $78-81 million, versus the consensus of $82.1 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.